Vanguard Fiduciary Trust
CRBU icon

Vanguard Fiduciary Trust’s Caribou Biosciences CRBU Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
606,388
+86,270
+17% +$171K ﹤0.01% 2995
2026
Q1 		$988K Buy
+520,118
New +$893K ﹤0.01% 2915

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Fiduciary Trust's CRBU Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Caribou Biosciences (CRBU) stake by 17% in Q2 2026, buying an estimated $171K and bringing the position to 606,388 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Vanguard Fiduciary Trust first reported a position in CRBU in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Vanguard Fiduciary Trust held 606,388 shares of Caribou Biosciences worth $1.07M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 86,270 Caribou Biosciences shares in Q2 2026, an estimated $171K.
  • Caribou Biosciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2995 holding.
  • Vanguard Fiduciary Trust first reported a position in Caribou Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.